Relay Therapeutics, Inc. (RLAY)
USD 2.65
(1.34%)
USD 2.65
(1.34%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -300.84 Million USD | 837.61% |
| 2022 | -2.74 Million USD | -206.81% |
| 2021 | -896 Thousand USD | -101.13% |
| 2020 | 79.1 Million USD | 2880.49% |
| 2019 | -2.84 Million USD | -32.08% |
| 2018 | -2.15 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -1.36 Million USD | -115.88% |
| 2024 Q1 | 8.61 Million USD | 725.87% |
| 2023 Q4 | -1.37 Million USD | -105.77% |
| 2023 Q1 | -971 Thousand USD | -6.35% |
| 2023 FY | 20.27 Million USD | 837.61% |
| 2023 Q2 | -1.21 Million USD | -25.13% |
| 2023 Q3 | 23.83 Million USD | 2062.06% |
| 2022 Q1 | -556 Thousand USD | -19.06% |
| 2022 Q4 | -913 Thousand USD | -32.51% |
| 2022 FY | -2.74 Million USD | -206.81% |
| 2022 Q3 | -688.99 Thousand USD | 98.85% |
| 2022 Q2 | -60.14 Million USD | -10717.63% |
| 2021 FY | -896 Thousand USD | -101.13% |
| 2021 Q3 | -43.48 Million USD | 1.84% |
| 2021 Q4 | -467 Thousand USD | 98.93% |
| 2021 Q2 | -44.3 Million USD | -49.32% |
| 2021 Q1 | -29.67 Million USD | -298.93% |
| 2020 Q1 | -21.7 Million USD | 0.0% |
| 2020 Q2 | -21.66 Million USD | 0.16% |
| 2020 Q4 | 14.91 Million USD | 161.19% |
| 2020 Q3 | -24.37 Million USD | -12.51% |
| 2020 FY | 79.1 Million USD | 2880.49% |
| 2019 Q4 | - USD | 0.0% |
| 2019 FY | -2.84 Million USD | -32.08% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | -2.15 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | 315.479% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -56985.579% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 1132.789% |
| Acelyrin, Inc. | -115 Thousand USD | -261500.87% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 322.402% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 6971.654% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 60753.427% |
| IO Biotech, Inc. | -756 Thousand USD | -39693.783% |
| Ardelyx, Inc. | 106.66 Million USD | 382.053% |
| Geron Corporation | -123.5 Million USD | -143.59% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 1914.81% |
| Innoviva, Inc. | 261.06 Million USD | 215.236% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -546883.636% |
| ChromaDex Corporation | 50.78 Million USD | 692.44% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 351.218% |
| Onconetix, Inc. | -1.12 Million USD | -26590.059% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -938.529% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -209836.428% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -183.483% |
| Vaxcyte, Inc. | -75 Million USD | -301.121% |
| Pharming Group N.V. | 220.1 Million USD | 236.681% |
| ContextLogic Inc. | 59 Million USD | 609.9% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -129572.845% |
| Pyxis Oncology, Inc. | -2 Million USD | -14942.05% |
| AlloVir, Inc. | -398 Thousand USD | -75488.191% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 1135.419% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -2993044.961% |
| Summit Therapeutics Inc. | -2.05 Million USD | -14575.171% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -52586.69% |
| Senti Biosciences, Inc. | -2.68 Million USD | -11112.859% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -6170.133% |
| Psyence Biomedical Ltd. | -240.00 USD | -125350316.667% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -680720.585% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -524689.799% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -366779.268% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 388.995% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 58515.728% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 29915.758% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -8048.456% |
| Elevation Oncology, Inc. | -39 Thousand USD | -771287.179% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 349.714% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -7531.591% |
| AbCellera Biologics Inc. | 38.02 Million USD | 891.166% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -58118.351% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -563.742% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 37611.347% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 1496.338% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -253793.545% |
| Vaxxinity, Inc. | -2.23 Million USD | -13366.473% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -1268.268% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -31595.032% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -6016720.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 7526.339% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -171963.508% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 71053.066% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 1679.798% |
| Opthea Limited | 21.72 Thousand USD | 1385187.477% |
| Avidity Biosciences, Inc. | -181.4 Million USD | -65.837% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -206.302% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -1212.627% |
| Molecular Templates, Inc. | 50.39 Million USD | 696.966% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 1123.721% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -61046.545% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 49499.179% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 11787.685% |
| ADMA Biologics, Inc. | 88.21 Million USD | 441.02% |
| Alkermes plc | 1.37 Billion USD | 121.884% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 119.82% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -592806.977% |
| AnaptysBio, Inc. | 14.78 Million USD | 2135.322% |
| Aptorum Group Limited | -1.11 Million USD | -26888.808% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 224.968% |
| Bicycle Therapeutics plc | -129.52 Million USD | -132.274% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 250800.833% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -210.305% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 3922.145% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -15817.513% |
| Chimerix, Inc. | 324 Thousand USD | 92952.16% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 195.909% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -865.234% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -287.692% |
| CRISPR Therapeutics AG | 240.95 Million USD | 224.853% |
| Precision BioSciences, Inc. | 40.47 Million USD | 843.331% |
| Dyadic International, Inc. | 922.95 Thousand USD | 32695.343% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 1528.427% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -206.471% |
| Fortress Biotech, Inc. | 57.85 Million USD | 620.009% |
| Fortress Biotech, Inc. | 57.85 Million USD | 620.009% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| ImmuCell Corporation | 4.39 Million USD | 6943.075% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -2152.167% |
| Immix Biopharma, Inc. | -5468.00 USD | -5501747.11% |
| Incyte Corporation | 3.44 Billion USD | 108.744% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -204553.741% |
| Jaguar Health, Inc. | 7.72 Million USD | 3994.886% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -542.287% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -45207.38% |
| MiMedx Group, Inc. | 266.84 Million USD | 212.741% |
| MEI Pharma, Inc. | 49.32 Million USD | 709.891% |
| Mesoblast Limited | -9.81 Million USD | -2965.115% |
| Novavax, Inc. | 639.93 Million USD | 147.011% |
| NextCure, Inc. | -3.68 Million USD | -8066.151% |
| Precigen, Inc. | 106 Thousand USD | 283912.264% |
| PureTech Health plc | -1.6 Million USD | -18667.374% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 374.06% |
| Seer, Inc. | 7.02 Million USD | 4381.215% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -2506908.333% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -4138.391% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -63295.674% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -2892601.923% |
| Soligenix, Inc. | 97.31 Thousand USD | 309254.155% |
| Century Therapeutics, Inc. | -10.8 Million USD | -2683.245% |
| Kura Oncology, Inc. | -849 Thousand USD | -35334.747% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -348.321% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 403.76% |
| Autolus Therapeutics plc | -4.86 Million USD | -6081.241% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 826.915% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -178972.024% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 417.601% |
| GRI Bio, Inc. | 10.84 Million USD | 2875.03% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 11944.199% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -3363.117% |
| IGM Biosciences, Inc. | -211.66 Million USD | -42.134% |
| INmune Bio, Inc. | 155 Thousand USD | 194190.968% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 585.705% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -19872.303% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -46293.576% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -1027573.02% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 74936.07% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -14972.194% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -96015.335% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 418.482% |
| Verastem, Inc. | -62 Thousand USD | -485127.419% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 12454.867% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -115164.751% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 10038.586% |
| Histogen Inc. | 3.76 Million USD | 8081.985% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 52313.114% |
| Surrozen, Inc. | -27.23 Million USD | -1004.815% |
| Organovo Holdings, Inc. | -5.38 Million USD | -5482.501% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -24868.545% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -1073.007% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 1600.304% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -15193889.899% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 5059.117% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -448040.203% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 294.353% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 206438.134% |
| Apollomics, Inc. | 127 Thousand USD | 236982.677% |
| Amarin Corporation plc | 165.54 Million USD | 281.732% |
| Turnstone Biologics Corp. | 16.5 Million USD | 1922.616% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -172.281% |
| Synaptogenix, Inc. | -6347.00 USD | -4739792.863% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -589784.314% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 286.435% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 117.116% |
| Better Therapeutics, Inc. | -2.72 Million USD | -10923.855% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -168.222% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 188.985% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -2637005.54% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -4705.767% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -27051.715% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 4210.972% |
| Insmed Incorporated | 239.63 Million USD | 225.541% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 8508.077% |
| OmniAb, Inc. | 14.66 Million USD | 2151.142% |
| Alector, Inc. | -95.05 Million USD | -216.498% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 339.483% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -592.177% |
| Zai Lab Limited | 170.9 Million USD | 276.03% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 467.43% |
| Aura Biosciences, Inc. | -1.29 Million USD | -23130.965% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 231516.154% |
| Immunic, Inc. | -111 Thousand USD | -270927.928% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 1997.572% |
| Veracyte, Inc. | 248.14 Million USD | 221.235% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 95.696% |
| FibroGen, Inc. | 128.9 Million USD | 333.384% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -53340502.837% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -2478.589% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 108.852% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 77437.018% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 184.662% |
| TG Therapeutics, Inc. | 219.1 Million USD | 237.303% |
| Galecto, Inc. | -830 Thousand USD | -36145.904% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -21621.372% |
| Fortrea Holdings Inc. | 424 Million USD | 170.953% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -249.137% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -52958.377% |
| XBiotech Inc. | -1.74 Million USD | -17150.057% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -27051.715% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -547.374% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -298.286% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 509.848% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 1890.401% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 177.329% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -505.96% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 192.07% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -2556.704% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 1330.383% |
| NexImmune, Inc. | -1.02 Million USD | -29251.143% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 5571229.63% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -4133.824% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 102.662% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -450078.82% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -8372.008% |
| Ainos, Inc. | -253.73 Thousand USD | -118465.973% |
| Pluri Inc. | 322 Thousand USD | 93528.882% |
| Prothena Corporation plc | -129.2 Million USD | -132.847% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 696.623% |
| Celularity Inc. | 6.75 Million USD | 4553.605% |
| Rallybio Corporation | -150 Thousand USD | -200460.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -822.627% |
| MeiraGTx Holdings plc | 287 Thousand USD | 104922.648% |
| Omeros Corporation | -69.77 Million USD | -331.134% |
| Humacyte, Inc. | -76.55 Million USD | -292.999% |
| Immunocore Holdings plc | 248.39 Million USD | 221.116% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -1883.262% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 582.256% |
| Blueprint Medicines Corporation | 236.58 Million USD | 227.16% |
| CalciMedica, Inc. | -58 Thousand USD | -518591.379% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -20996.844% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -10478.094% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -874.699% |
| Pulmatrix, Inc. | -8.22 Million USD | -3559.866% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -25612.906% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -75298.747% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 24.562% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 10938.832% |
| Cytokinetics, Incorporated | -322.59 Million USD | 6.743% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 34996.097% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -88123.167% |
| Vor Biopharma Inc. | -3.49 Million USD | -8515.149% |
| Roivant Sciences Ltd. | 109.23 Million USD | 375.407% |
| Evogene Ltd. | 1.39 Million USD | 21604.003% |
| ProKidney Corp. | -3.16 Million USD | -9393.247% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -585.1% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 4487.356% |
| CorMedix Inc. | -205.56 Thousand USD | -146250.493% |
| BioLineRx Ltd. | 1.1 Million USD | 27251.715% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -282.404% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -911539.394% |
| Atai Life Sciences N.V. | -5000.00 USD | -6016720.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -246776.308% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -313276.042% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -21558.819% |
| Sagimet Biosciences Inc. | 2 Million USD | 15142.05% |
| MediciNova, Inc. | 979.7 Thousand USD | 30807.305% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -256.789% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -318065.089% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1351.882% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 223.026% |
| Biomea Fusion, Inc. | -4.2 Million USD | -7061.176% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 134.487% |
| Mereo BioPharma Group plc | 7.42 Million USD | 4151.185% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -96945.484% |
| Absci Corporation | -41.84 Million USD | -618.873% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -6016720.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -293.91% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -12124.34% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 240.754% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -31870.351% |
| Allakos Inc. | -6.14 Million USD | -4798.893% |
| Imunon, Inc. | -720 Thousand USD | -41683.182% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -336.027% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 163.216% |
| BioAtla, Inc. | -103.73 Million USD | -190.02% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -2637005.54% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -168911.798% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | -23.895% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -96633.441% |
| XOMA Corporation | 3.86 Million USD | 7891.79% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -329.252% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 2133.534% |
| aTyr Pharma, Inc. | -2.38 Million USD | -12498.032% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 2514.454% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -1037282.759% |
| Viridian Therapeutics, Inc. | -1 Million USD | -29745.337% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 2314161638.462% |
| Akari Therapeutics, Plc | -4000.00 USD | -7520925.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 147.236% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 154608.803% |
| UroGen Pharma Ltd. | 73.35 Million USD | 510.133% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -1026.999% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 2591323.084% |
| Orgenesis Inc. | -5.72 Million USD | -5154.865% |
| Entera Bio Ltd. | -56 Thousand USD | -537116.071% |
| GH Research PLC | -315 Thousand USD | -95405.079% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -159075.132% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -57203.048% |
| Xencor, Inc. | -85.26 Million USD | -252.851% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -136041.318% |
| Replimune Group, Inc. | -2.65 Million USD | -11231.111% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -29946.962% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 269.16% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 154608.803% |
| Portage Biotech Inc. | -54 Thousand USD | -557012.963% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -318065.089% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -79698.674% |
| OncoCyte Corporation | 413 Thousand USD | 72942.857% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -6692691.991% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -135513863.964% |
| Purple Biotech Ltd. | -196 Thousand USD | -153390.306% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 3454.605% |
| scPharmaceuticals Inc. | 9.78 Million USD | 3175.455% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -2780.251% |
| HilleVax, Inc. | -2.15 Million USD | -13853.664% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -310045.361% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -2004971.981% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -44936.078% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -1307904.348% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -4007821.494% |
| Savara Inc. | -44.26 Million USD | -579.682% |
| Curis, Inc. | 9.81 Million USD | 3166.364% |
| Daré Bioscience, Inc. | 2.76 Million USD | 10962.56% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -240981.675% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -17299.711% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -131847.807% |
| BeiGene, Ltd. | 2.07 Billion USD | 114.471% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -10660.077% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 24.727% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 630.696% |
| Erasca, Inc. | -3.73 Million USD | -7961.12% |
| bluebird bio, Inc. | -4.03 Million USD | -7365.037% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1066031.547% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 115.797% |
| DBV Technologies S.A. | 15.72 Million USD | 2012.773% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1066031.547% |
| Moderna, Inc. | 2.15 Billion USD | 113.96% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -32778.798% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 3857.694% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -56027.052% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 324.864% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -4735.117% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -664.662% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -170.716% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -8284.643% |
| MacroGenics, Inc. | 50.52 Million USD | 695.406% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -4833.437% |
| Prime Medicine, Inc. | -147.9 Million USD | -103.402% |
| Aditxt, Inc. | -111.66 Thousand USD | -269325.936% |
| Adagene Inc. | 18.11 Million USD | 1761.05% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 61747.746% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 314.577% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 290.604% |
| SciSparc Ltd. | 2.19 Million USD | 13799.499% |
| Vericel Corporation | 135.57 Million USD | 321.898% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1200910.02% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -970918.656% |
| Generation Bio Co. | -73.91 Million USD | -307.031% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -68742.334% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 650.799% |
| Invivyd, Inc. | -2.02 Million USD | -14734.369% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -290741.857% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 412.179% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 406.081% |
| Clene Inc. | 533 Thousand USD | 56542.964% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 1347.827% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -31335.841% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1351.882% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 15232.847% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -154720.499% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 704.038% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -4141.977% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -35885.766% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 460.656% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 411579.648% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 665.895% |
| Verve Therapeutics, Inc. | -173.18 Million USD | -73.708% |
| Trevena, Inc. | 1.45 Million USD | 20776.357% |
| Surrozen, Inc. | -27.23 Million USD | -1004.815% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -85124.079% |
| Cingulate Inc. | -582.91 Thousand USD | -51509.489% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -970354.839% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -1427.189% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -3974021.532% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -34047.673% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 144.195% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -30349.494% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -533855.131% |
| Kronos Bio, Inc. | 1.37 Million USD | 22027.187% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -460.58% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -102927.74% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -61508.105% |
| ImmunityBio, Inc. | -17.89 Million USD | -1581.615% |
| Korro Bio, Inc. | -3.63 Million USD | -8187.631% |
| Kineta, Inc. | 5.43 Million USD | 5637.291% |
| BioVie Inc. | -229.37 Thousand USD | -131055.696% |
| Codexis, Inc. | 57.33 Million USD | 624.717% |
| Celularity Inc. | 6.75 Million USD | 4553.605% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 7596.661% |
| Celcuity Inc. | -142.77 Thousand USD | -210614.286% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 594764.954% |
| Cibus, Inc. | 1.42 Million USD | 21256.188% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -80338.77% |
| IN8bio, Inc. | -2.5 Million USD | -11928.828% |
| Kodiak Sciences Inc. | -25.94 Million USD | -1059.444% |
| Annexon, Inc. | -3.26 Million USD | -9108.479% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -14618.249% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -620.802% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 47106.406% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 138.643% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 273.942% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -15733.737% |
| Arcellx, Inc. | 108.27 Million USD | 377.839% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -829.411% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 479.831% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -1322.282% |
| Moolec Science SA | -143.3 Thousand USD | -209830.568% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -610.906% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 9252.449% |
| Royalty Pharma plc | 1.79 Billion USD | 116.77% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -329.221% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -8328831.34% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 130114.132% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -170.021% |
| Humacyte, Inc. | -76.55 Million USD | -292.999% |
| 89bio, Inc. | -273 Thousand USD | -110098.168% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -23833.254% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -35376.533% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -244486.179% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 26984.808% |
| Notable Labs, Ltd. | 113 Thousand USD | 266330.973% |
| Liquidia Corporation | 14.6 Million USD | 2160.555% |
| Mustang Bio, Inc. | -2.22 Million USD | -13420.944% |
| Immunovant, Inc. | -231 Thousand USD | -130134.199% |
| Quantum-Si incorporated | 488 Thousand USD | 61747.746% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -441.48% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -1002703.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 16256.874% |
| Acasti Pharma Inc. | -11 Thousand USD | -2734818.182% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -146926.396% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -46293.576% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | -79.594% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 26615.627% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -78860.892% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -15264.709% |
| PepGen Inc. | -1.18 Million USD | -25308.868% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -236782.677% |
| United Therapeutics Corporation | 2.07 Billion USD | 114.533% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1213.888% |
| Solid Biosciences Inc. | -76.56 Million USD | -292.933% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -364189.261% |
| Immuneering Corporation | -764.13 Thousand USD | -39269.983% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 454103.682% |
| Belite Bio, Inc | -399 Thousand USD | -75298.747% |
| XOMA Corporation | 3.86 Million USD | 7891.79% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -1401.502% |
| Bionomics Limited | -434.44 Thousand USD | -69146.563% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -27911.266% |
| uniQure N.V. | 2.21 Million USD | 13681.986% |
| Cassava Sciences, Inc. | -89.42 Million USD | -236.425% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -226.756% |
| Forte Biosciences, Inc. | -9000.00 USD | -3342577.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -35928.862% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -68742.334% |
| Altimmune, Inc. | -65.37 Million USD | -360.192% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 183.098% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -27911.266% |
| Compugen Ltd. | 31.45 Million USD | 1056.417% |
| Peak Bio, Inc. | 367.76 Thousand USD | 81901.62% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 1327.121% |
| Benitec Biopharma Inc. | 108 Thousand USD | 278656.481% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -385593.59% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -24907.564% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -16411.581% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -252707.563% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -24907.564% |
| Instil Bio, Inc. | -4.75 Million USD | -6225.505% |
| argenx SE | 1.1 Billion USD | 127.14% |
| Immunome, Inc. | -8.9 Million USD | -3277.579% |
| Verona Pharma plc | -679.62 Thousand USD | -44165.8% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -171809.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | -12513.878% |
| CervoMed Inc. | -1.29 Million USD | -23155.622% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -12398.587% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -6197.697% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 12274.868% |
| Moolec Science SA | -143.3 Thousand USD | -209830.568% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -73630.118% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -11161.009% |
| Design Therapeutics, Inc. | -537 Thousand USD | -55922.533% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -70354.567% |
| NeurAxis, Inc. | 2.15 Million USD | 14049.109% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 14118.686% |
| Lumos Pharma, Inc. | 2 Million USD | 15089.586% |
| Achilles Therapeutics plc | -4.73 Million USD | -6258.572% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -171809.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -284585.119% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 1050.262% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 34996.097% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -29051.26% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -560.492% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 699730.233% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -36498.662% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -2286273.309% |
| Palisade Bio, Inc. | 246 Thousand USD | 122393.089% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -911539.394% |
| Beam Therapeutics Inc. | -59.67 Million USD | -404.158% |
| Neurogene Inc. | -3.26 Million USD | -9122.594% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 315.912% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 852.103% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -101193.266% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -7370.53% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -3044.899% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 2236.655% |
| Athira Pharma, Inc. | -969 Thousand USD | -30946.543% |
| Vaccinex, Inc. | -16 Million USD | -1779.786% |
| HCW Biologics Inc. | -574.82 Thousand USD | -52236.193% |
| XOMA Corporation | 3.86 Million USD | 7891.79% |
| Nektar Therapeutics | 53.47 Million USD | 662.551% |
| Arvinas, Inc. | 71.8 Million USD | 518.999% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -260.457% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -379.237% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -93328.882% |
| Rezolute, Inc. | -36 Thousand USD | -835569.444% |
| Clene Inc. | 533 Thousand USD | 56542.964% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -23429884.424% |
| BeyondSpring Inc. | 1.75 Million USD | 17281.097% |
| Synlogic, Inc. | -1.92 Million USD | -15536.227% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -812983.784% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -4651.121% |
| Peak Bio, Inc. | 367.76 Thousand USD | 81901.62% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -1486.463% |
| Krystal Biotech, Inc. | 47.6 Million USD | 731.953% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 313.225% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 6086.886% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -11518.986% |
| MannKind Corporation | 136.19 Million USD | 320.896% |
| Ikena Oncology, Inc. | -50.49 Million USD | -495.819% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 376.473% |
| Gossamer Bio, Inc. | -4.38 Million USD | -6760.684% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -119281.349% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -6016720.0% |
| Legend Biotech Corporation | 140.92 Million USD | 313.47% |
| Mural Oncology plc | -2.56 Million USD | -11619.556% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -54499.093% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -300741.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 1549.557% |
| REGENXBIO Inc. | 53.02 Million USD | 667.314% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -5515.898% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -156282.586% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -17269.573% |
| Vaxart, Inc. | -60.76 Million USD | -395.106% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -114383.979% |
| Cellectis S.A. | 18 Thousand USD | 1671438.889% |
| Longeveron Inc. | 221 Thousand USD | 136227.149% |
| Repare Therapeutics Inc. | -80.07 Million USD | -275.722% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 127.525% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -23148.918% |
| Revolution Medicines, Inc. | -399.66 Million USD | 24.727% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -859445.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 614061.224% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 103.495% |
| Denali Therapeutics Inc. | -93.34 Million USD | -222.289% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1200910.02% |
| Veru Inc. | 7.56 Million USD | 4076.26% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -199132.45% |
| Cingulate Inc. | -582.91 Thousand USD | -51509.489% |
| Passage Bio, Inc. | -3.72 Million USD | -7984.95% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -2497749.552% |
| Exicure, Inc. | -1.42 Million USD | -21041.321% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -78448.564% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 11229.893% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -58580.646% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 541.595% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -200987.516% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -408.126% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 77041.432% |
| OmniAb, Inc. | 14.66 Million USD | 2151.142% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 1604.732% |
| Lipocine Inc. | -2.85 Million USD | -10452.796% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -16223.44% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -5173.287% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -19872.303% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 499.438% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -462732.308% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 456.886% |
| Ocugen, Inc. | -33.53 Million USD | -797.042% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -9414.263% |
| Q32 Bio Inc. | 578 Thousand USD | 52148.616% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -113424.906% |
| Alumis Inc. Common Stock | -1.28 Million USD | -23329.984% |
| Equillium, Inc. | 35.95 Million USD | 936.646% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -17523.96% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 60186.602% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -7277137.542% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -116054.826% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 71269.259% |
| Dominari Holdings Inc. | 2.03 Million USD | 14854.34% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -163871.963% |
| vTv Therapeutics Inc. | -13.59 Million USD | -2112.88% |
| Bio-Techne Corporation | 773.07 Million USD | 138.915% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 1837.058% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 165.289% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -25634.902% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -1154.55% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 2671.95% |
| Nkarta, Inc. | -5.86 Million USD | -5025.933% |
| BioCardia, Inc. | -7.24 Million USD | -4050.103% |
| Iterum Therapeutics plc | -1.75 Million USD | -17090.914% |